Valuation: BAYER

Market Cap 4.91TCr 5.6TCr 4.64TCr 4.23TCr 7.92TCr 5,36700Cr 7.97TCr 56TCr 22TCr 2,74200Cr 21TCr 21TCr 8,81300Cr P/E 2026 *
22.6x
P/E 2027 * 16.3x
Enterprise Value 7.91TCr 9.01TCr 7.47TCr 6.81TCr 13TCr 8,63900Cr 13TCr 89TCr 35TCr 4,41300Cr 34TCr 33TCr 14,18400Cr EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.61x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.12%
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.13%+2.65%+63.34%+115.17% 1,05500Cr
+0.20%+0.46%+50.92%+70.56% 65TCr
-0.29%+0.14%+19.82%+71.75% 47TCr
-0.85%+0.98%+42.13%+44.64% 35TCr
+0.71%+4.08%+21.75%+28.83% 27TCr
+1.23%+0.42%+14.11%+12.43% 26TCr
+2.11%+7.51%+51.88%+54.11% 22TCr
+0.83%+0.55%+34.64%+99.83% 19TCr
0.00%-10.14%-27.40%-61.08% 17TCr
Average +0.45%+0.74%+30.13%+48.47% 40.43TCr
Weighted average by Cap. +0.27%+1.32%+40.43%+68.22%

Financials

2026 *2027 *
Net sales 4.58TCr 5.22TCr 4.33TCr 3.94TCr 7.38TCr 5,00600Cr 7.44TCr 52TCr 20TCr 2,55700Cr 20TCr 19TCr 8,21900Cr 4.7TCr 5.36TCr 4.44TCr 4.05TCr 7.58TCr 5,13900Cr 7.63TCr 53TCr 21TCr 2,62500Cr 20TCr 20TCr 8,43800Cr
Net income 214.66Cr 244.62Cr 202.73Cr 184.76Cr 345.85Cr 23TCr 348.32Cr 2.43TCr 939.65Cr 12TCr 918.47Cr 898.6Cr 38TCr 294.42Cr 335.52Cr 278.07Cr 253.41Cr 474.37Cr 32TCr 477.75Cr 3.33TCr 1.29TCr 16TCr 1.26TCr 1.23TCr 53TCr
Net Debt 3TCr 3.41TCr 2.83TCr 2.58TCr 4.83TCr 3,27100Cr 4.86TCr 34TCr 13TCr 1,67100Cr 13TCr 13TCr 5,37100Cr 2.68TCr 3.06TCr 2.53TCr 2.31TCr 4.32TCr 2,93000Cr 4.35TCr 30TCr 12TCr 1,49700Cr 11TCr 11TCr 4,81000Cr
Logo BAYER
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-